Versant Venture Management as of Sept. 30, 2019
Portfolio Holdings for Versant Venture Management
Versant Venture Management holds 8 positions in its portfolio as reported in the September 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Crispr Therapeutics (CRSP) | 67.2 | $174M | 4.2M | 40.99 | |
| Veracyte (VCYT) | 11.2 | $29M | 1.2M | 24.00 | |
| Gritstone Oncology Ord (GRTS) | 10.4 | $27M | 3.1M | 8.63 | |
| Audentes Therapeutics | 6.0 | $16M | 554k | 28.09 | |
| Ocular Therapeutix (OCUL) | 2.6 | $6.7M | 2.2M | 3.04 | |
| Second Sight Med Prods | 1.4 | $3.7M | 4.5M | 0.82 | |
| Cymabay Therapeutics | 1.1 | $2.8M | 544k | 5.12 | |
| Clovis Oncology | 0.1 | $400k | 102k | 3.93 |
